Free Trial

Akebia Therapeutics (AKBA) SEC Filings & 10K Form

Akebia Therapeutics logo
$1.80 -0.11 (-5.76%)
Closing price 04:00 PM Eastern
Extended Trading
$1.80 -0.01 (-0.28%)
As of 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Akebia Therapeutics SEC Filings

DateFilerForm TypeView
02/07/2025
7:16 AM
Akebia Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/04/2025
4:48 PM
Akebia Therapeutics (Issuer)
Ostrowski Erik (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/04/2025
4:51 PM
Akebia Therapeutics (Issuer)
Grund Nicholas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/04/2025
4:52 PM
Akebia Therapeutics (Issuer)
Malabre Richard C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/04/2025
4:53 PM
Akebia Therapeutics (Issuer)
Burke Steven Keith (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/04/2025
4:54 PM
Akebia Therapeutics (Issuer)
Butler John P. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/03/2025
4:50 PM
Akebia Therapeutics (Subject)
Butler John P. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/03/2025
4:58 PM
Akebia Therapeutics (Subject)
Burke Steven Keith (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/03/2025
5:02 PM
Akebia Therapeutics (Subject)
Grund Nicholas (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/30/2025
6:40 AM
Akebia Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
01/13/2025
7:05 AM
Akebia Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/07/2024
6:05 AM
Akebia Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/07/2024
6:16 AM
Akebia Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/22/2024
5:06 PM
Akebia Therapeutics (Subject)
BlackRock, Inc. (Filed by)
Form SC 13G
10/22/2024
7:05 AM
Akebia Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/16/2024
6:36 AM
Akebia Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/12/2024
11:15 PM
Akebia Therapeutics (Filer)
Form EFFECT
08/08/2024
6:52 AM
Akebia Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/08/2024
6:06 AM
Akebia Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/11/2024
5:05 AM
Akebia Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/02/2024
3:31 PM
Akebia Therapeutics (Issuer)
Akebia Therapeutics (Issuer)
Ostrowski Erik (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/26/2024
4:37 PM
Akebia Therapeutics (Issuer)
Ostrowski Erik (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
06/24/2024
8:03 AM
Akebia Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/10/2024
3:18 PM
ADAMS ADRIAN (Reporting)
Akebia Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2024
3:18 PM
Akebia Therapeutics (Issuer)
ZUMWALT LEANNE M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2024
3:19 PM
Akebia Therapeutics (Issuer)
FRIESON RON (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2024
3:19 PM
Akebia Therapeutics (Issuer)
GILMAN STEVEN C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2024
3:19 PM
Akebia Therapeutics (Issuer)
ROGERS MICHAEL W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2024
3:20 PM
Akebia Therapeutics (Issuer)
Smith Cynthia (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2024
3:20 PM
Akebia Therapeutics (Issuer)
Wolf Myles (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/14/2024
3:04 PM
Akebia Therapeutics (Issuer)
Dahan Michel (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/14/2024
3:05 PM
Akebia Therapeutics (Issuer)
Hadas Nicole R. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/13/2024
6:17 PM
Akebia Therapeutics (Subject)
Hadas Nicole R. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/13/2024
6:19 PM
Akebia Therapeutics (Subject)
Dahan Michel (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/09/2024
4:27 PM
Akebia Therapeutics (Issuer)
Burke Steven Keith (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/09/2024
6:03 AM
Akebia Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/09/2024
6:05 AM
Akebia Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/25/2024
4:17 PM
Akebia Therapeutics (Filer)
Form DEF 14A
04/25/2024
4:18 PM
Akebia Therapeutics (Filer)
Form DEFA14A
04/25/2024
4:19 PM
Akebia Therapeutics (Filer)
Form ARS
04/23/2024
7:32 AM
Akebia Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
70%, 80%, 90% Win Rates? Grab Your Free Cheatsheets Today! (Ad)

Would you like to know the historic win rate of every trade you take before you place it? Well, it’s all possible with these FIVE Candlestick Pattern Cheatsheets.

>> You can grab your FREE, laminated copies right here << 
04/16/2024
6:33 AM
Akebia Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/14/2024
4:19 PM
Akebia Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/01/2024
4:48 PM
Akebia Therapeutics (Issuer)
Hadas Nicole R. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/01/2024
4:49 PM
Akebia Therapeutics (Issuer)
Dahan Michel (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/01/2024
4:46 PM
Akebia Therapeutics (Issuer)
Burke Steven Keith (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/01/2024
4:47 PM
Akebia Therapeutics (Issuer)
Butler John P. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/29/2024
5:00 PM
Akebia Therapeutics (Issuer)
Butler John P. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/29/2024
5:01 PM
Akebia Therapeutics (Issuer)
Burke Steven Keith (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/29/2024
5:02 PM
Akebia Therapeutics (Issuer)
Dahan Michel (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/29/2024
5:03 PM
Akebia Therapeutics (Issuer)
Hadas Nicole R. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/29/2024
3:32 PM
Akebia Therapeutics (Subject)
Butler John P. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/27/2024
5:11 PM
Akebia Therapeutics (Subject)
Butler John P. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/27/2024
5:14 PM
Akebia Therapeutics (Subject)
Burke Steven Keith (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/27/2024
5:16 PM
Akebia Therapeutics (Subject)
Dahan Michel (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/27/2024
5:19 PM
Akebia Therapeutics (Subject)
Hadas Nicole R. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:AKBA) was last updated on 2/21/2025 by MarketBeat.com Staff
From Our Partners